Browsing "1. Journal Papers" by Author : 4469

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 66 to 125 of 397

This table browses all dspace content
Issue DateTitleJournal Title
2012Decreased endothelial progenitor cells and increased serum glycated albumin are independently correlated with plaque-forming carotid artery atherosclerosis in type 2 diabetes patients without documented ischemic disease. CIRCULATION JOURNAL
2013Decreased Expression of Hepatic Low-Density Lipoprotein Receptor–Related Protein 1 in Hypothyroidism: A Novel Mechanism of Atherogenic Dyslipidemia in HypothyroidismTHYROID
2006Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes EUROPEAN JOURNAL OF ENDOCRINOLOGY
2003Delayed treatment with lithospermate B attenuates experimental diabetic renal injury JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
2016Depot-Specific Changes in Fat Metabolism with Aging in a Type 2 Diabetic Animal Model PLOS ONE
2007Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal modelMETABOLISM-CLINICAL AND EXPERIMENTAL
2014Development of an HbA1c-Based Conversion Equation for Estimating Glycated Albumin in a Korean Population with a Wide Range of Glucose Intolerance. PLOS ONE
2017Diabetes self-assessment score and the development of diabetes A 10-year prospective study MEDICINE
2010Dietary monounsaturated fatty acids but not saturated fatty acids preserve the insulin signaling pathway via IRS-1/PI3K in rat skeletal muscleLIPIDS
2011Dietary oleate has beneficial effects on every step of non-alcoholic Fatty liver disease progression in a methionine- and choline-deficient diet-fed animal model. DIABETES & METABOLISM JOURNAL
2018Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study SCIENTIFIC REPORTS
2019Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and β-Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis DIABETES THERAPY
2012Dimethyl sulfoxide reduces hepatocellular lipid accumulation through autophagy induction AUTOPHAGY
2020Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression SCIENTIFIC REPORTS
2006Does birthweight predict adolescent adiponectin levels?CLINICAL ENDOCRINOLOGY
2012Dual pathways of p53 mediated glucolipotoxicity-induced apoptosis of rat cardiomyoblast cell: activation of p53 proapoptosis and inhibition of Nrf2-NQO1 antiapoptosis.METABOLISM-CLINICAL AND EXPERIMENTAL
2005Duodenal Somatostatinoma Associated with Diabetic Ketoacidosis Presumably Caused by Somatostatin-28 HypersecretionJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
2008Echogenic carotid artery plaques are associated with vertebral fractures in postmenopausal women with low bone mass.CALCIFIED TISSUE INTERNATIONAL
2009Effect of ABCA1 variant on atherogenic dyslipidaemia in patients with Type 2 diabetes treated with rosiglitazoneDIABETIC MEDICINE
2014Effect of cilostazol on carotid intima-media thickness in type 2 diabetic patients without caridiovascular eventENDOCRINE
1997Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormoneINTERNATIONAL JOURNAL OF OBESITY
2011Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus EUROPEAN JOURNAL OF ENDOCRINOLOGY
2020Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
2022Effects of a Phosphodiesterase inhibitor on the Browning of Adipose Tissue in Mice BIOMEDICINES
2018Effects of Combination Therapy of Statin and Thiazolidinedione on Vascular Inflammation KOREAN CIRCULATION JOURNAL
2006Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic controlCLINICAL ENDOCRINOLOGY
2006Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitusMETABOLISM-CLINICAL AND EXPERIMENTAL
2018Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db miceINTERNATIONAL JOURNAL OF OBESITY
2016Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia. PLOS ONE
2010Effects of pioglitazone on subclinical atherosclerosis and insulin resistance in nondiabetic renal allograft recipients. NEPHROLOGY DIALYSIS TRANSPLANTATION
2005Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 gene on rosiglitazone response in type 2 diabetesCLINICAL PHARMACOLOGY & THERAPEUTICS
2007Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitusCLINICAL ENDOCRINOLOGY
2008Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patientsMETABOLISM-CLINICAL AND EXPERIMENTAL
2018Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer Endocrinology and Metabolism (대한내분비학회지)
2019Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trialDIABETES OBESITY & METABOLISM
2019Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes MellitusTRANSPLANTATION PROCEEDINGS
2018Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial DIABETES OBESITY & METABOLISM
2020Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeksDIABETES OBESITY & METABOLISM
2016Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis MEDICINE
2016Efficacy, safety, and tolerability of ipragliflozin in Asian patients with type 2 diabetes mellitus and inadequate glycemic control with metformin: Results of a phase 3 randomized, placebo-controlled, double-blind, multicenter trial JOURNAL OF DIABETES INVESTIGATION
2018Elevated N-acetyl-beta-D-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional studyJOURNAL OF DIABETES AND ITS COMPLICATIONS
2012Epicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance. CARDIOVASCULAR DIABETOLOGY
2016Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPKINTERNATIONAL JOURNAL OF OBESITY
2017Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibitionAUTOPHAGY
2022Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study) BMC MEDICINE
2016Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitisFREE RADICAL BIOLOGY AND MEDICINE
2011Fat redistribution preferentially reflects the anti-inflammatory benefits of pioglitazone treatment.METABOLISM-CLINICAL AND EXPERIMENTAL
2022Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease GUT AND LIVER
2002Free fatty acid metabolism in human skeletal muscle is regulated by PPARgamma and RXR agonistsANNALS OF THE NEW YORK ACADEMY OF SCIENCES
2006Frequent, Aggressive Behaviors of Thyroid Microcarcinomas in Korean Patients ENDOCRINE JOURNAL
2020Gamma Glutamyltransferase and Risk of Dementia in Prediabetes and Diabetes SCIENTIFIC REPORTS
2013Gastrectomy for Early Gastric Cancer is Associated with Decreased Cardiovascular Mortality in Association with Postsurgical Metabolic ChangesANNALS OF SURGICAL ONCOLOGY
2019Glucometabolic characteristics and higher vascular complication risk in Korean patients with type 2 diabetes with non-albumin proteinuriaJournal of Diabetes and Its Complications
2015Glycated albumin and the risk of micro- and macrovascular complications in subjects with type 1 diabetes CARDIOVASCULAR DIABETOLOGY
2013Glycated Albumin Causes Pancreatic β-Cells Dysfunction Through Autophagy DysfunctionENDOCRINOLOGY
2011Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patientsACTA DIABETOLOGICA
2015Glycated Albumin Levels in Patients with Type 2 Diabetes Increase Relative to HbA1c with Time BIOMED RESEARCH INTERNATIONAL
2013Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients DIABETES & METABOLISM JOURNAL
2012Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus. DIABETES & METABOLISM JOURNAL
2004Graves' Disease Associated with Klinefelter's Syndrome YONSEI MEDICAL JOURNAL

Browse

Links